AU2001292617A1 - Mammalian receptor genes and uses - Google Patents
Mammalian receptor genes and usesInfo
- Publication number
- AU2001292617A1 AU2001292617A1 AU2001292617A AU9261701A AU2001292617A1 AU 2001292617 A1 AU2001292617 A1 AU 2001292617A1 AU 2001292617 A AU2001292617 A AU 2001292617A AU 9261701 A AU9261701 A AU 9261701A AU 2001292617 A1 AU2001292617 A1 AU 2001292617A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor genes
- mammalian receptor
- mammalian
- genes
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108020003175 receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/659,519 | 2000-09-12 | ||
| US09/659,519 US6783973B1 (en) | 2000-09-12 | 2000-09-12 | Mammalian catecholamine receptor genes and uses |
| US30396701P | 2001-07-09 | 2001-07-09 | |
| US60/303,967 | 2001-07-09 | ||
| PCT/US2001/028455 WO2002022801A2 (en) | 2000-09-12 | 2001-09-12 | Mammalian receptor genes and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001292617A1 true AU2001292617A1 (en) | 2002-03-26 |
Family
ID=26973745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001292617A Abandoned AU2001292617A1 (en) | 2000-09-12 | 2001-09-12 | Mammalian receptor genes and uses |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1319070A2 (en) |
| AU (1) | AU2001292617A1 (en) |
| CA (1) | CA2422288A1 (en) |
| WO (1) | WO2002022801A2 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083851A2 (en) * | 2003-03-18 | 2004-09-30 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) |
| EP1621552A1 (en) * | 2004-07-08 | 2006-02-01 | F.Hoffmann-La Roche Ag | Human trace amine associated receptors (hTAAR) |
| EP1626057A1 (en) * | 2004-07-30 | 2006-02-15 | F.Hoffmann-La Roche Ag | Chimpanzee trace amine associated receptors |
| US7368541B2 (en) | 2004-12-01 | 2008-05-06 | Merck & Co., Inc. | Trace amine receptor 1 of the African green monkey |
| JP2009524618A (en) * | 2006-01-27 | 2009-07-02 | エフ.ホフマン−ラ ロシュ アーゲー | Use of 2-imidazole in the treatment of CNS disorders |
| AU2007209381A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of substituted 2-imidazole of imidazoline derivatives |
| JP2009524619A (en) * | 2006-01-27 | 2009-07-02 | エフ.ホフマン−ラ ロシュ アーゲー | Use of 2-imidazole for the treatment of CNS disorders |
| CA2666762C (en) | 2006-10-19 | 2014-12-30 | F. Hoffmann-La Roche Ag | Aminomethyl-4-imidazoles |
| JP5064511B2 (en) | 2006-11-02 | 2012-10-31 | エフ.ホフマン−ラ ロシュ アーゲー | Substituted 2-imidazoles as trace amine-related receptor modulators |
| RU2456281C2 (en) | 2006-11-16 | 2012-07-20 | Ф. Хоффманн-Ля Рош Аг | Substituted 4-imidazoles, method for preparing and using them |
| ATE509628T1 (en) | 2006-12-13 | 2011-06-15 | Hoffmann La Roche | NEW 2-IMIDAZOLES AS LIGANDS FOR TRACE AMINE ASSOCIATED RECEPTORS (TAAR) |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| JP5248528B2 (en) | 2007-02-02 | 2013-07-31 | エフ.ホフマン−ラ ロシュ アーゲー | Novel 2-aminooxazolines as TAAR1 ligands for CNS diseases |
| MX2009008465A (en) | 2007-02-15 | 2009-08-20 | Hoffmann La Roche | 2-aminooxazolines as taar1 ligands. |
| JP2010531837A (en) | 2007-07-02 | 2010-09-30 | エフ.ホフマン−ラ ロシュ アーゲー | 2-Imidazoline with good affinity for trace amine-related receptors (TAAR) |
| CA2691704A1 (en) | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| KR101133862B1 (en) | 2007-07-27 | 2012-04-06 | 에프. 호프만-라 로슈 아게 | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| AU2008285795A1 (en) | 2007-08-03 | 2009-02-12 | F. Hoffmann-La Roche Ag | Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands |
| US8242153B2 (en) | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| PE20181446A1 (en) | 2016-03-17 | 2018-09-12 | Hoffmann La Roche | DERIVATIVES OF 5-ETHYL-4-METHYL-PIRAZOL-3-CARBOXAMIDE WITH ACTIVITY AS OF TAAR |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277591B1 (en) * | 1988-11-18 | 2001-08-21 | Oregon Health Science University | Dopamine receptors and genes |
| US5871967A (en) * | 1997-01-24 | 1999-02-16 | Smithkline Beecham Corporation | Cloning of a novel G-Protein coupled 7TM receptor |
| US6987005B1 (en) * | 1999-05-28 | 2006-01-17 | H. Lundbeck A/S | DNA encoding SNORF33 receptor |
| AU784543B2 (en) * | 1999-11-16 | 2006-04-27 | Pharmacia & Upjohn Company | Novel G protein-coupled receptors |
| US6890731B1 (en) * | 2000-03-27 | 2005-05-10 | Applera Corporation | Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
-
2001
- 2001-09-12 AU AU2001292617A patent/AU2001292617A1/en not_active Abandoned
- 2001-09-12 WO PCT/US2001/028455 patent/WO2002022801A2/en not_active Ceased
- 2001-09-12 EP EP01972993A patent/EP1319070A2/en not_active Withdrawn
- 2001-09-12 CA CA002422288A patent/CA2422288A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002022801A2 (en) | 2002-03-21 |
| WO2002022801A3 (en) | 2003-03-06 |
| WO2002022801A9 (en) | 2003-07-03 |
| EP1319070A2 (en) | 2003-06-18 |
| CA2422288A1 (en) | 2002-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001292617A1 (en) | Mammalian receptor genes and uses | |
| AU2002210295A1 (en) | Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof | |
| AU2002225756A1 (en) | Uses of mammalian genes and related reagents | |
| EP1130098A3 (en) | Mammalian osteoregulins | |
| AU2002225681A1 (en) | Yeast-dentritic cell vaccines and uses thereof | |
| AU2002314433A1 (en) | Ephrin-tie receptor materials and methods | |
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU5898800A (en) | Atherosclerosis-associated genes | |
| AU2002329759A1 (en) | Methyltransferase genes and uses thereof | |
| AU2088801A (en) | Metastasis genes and uses thereof | |
| AU7039400A (en) | Solid soap with connecting and keeping means | |
| AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
| AU2001293074A1 (en) | Human liver cell line | |
| AU2001240103A1 (en) | Reproduction-specific genes | |
| EP1144631A3 (en) | Insulin-synthesis genes | |
| AU2400401A (en) | Novel phosphodiesterases and genes thereof | |
| AU3244801A (en) | Modified DHPS genes | |
| AU2001223882A1 (en) | Receptor | |
| AU2001288985A1 (en) | Uses of mammalian genes and related reagents | |
| AU5617200A (en) | Nodavirus-based dna expression vector and uses thereof | |
| AU1894601A (en) | Novel gene and use thereof | |
| AU7024500A (en) | Essential genes and assays relating thereto | |
| AU6878200A (en) | Novel receptors and genes encoding the same | |
| AUPQ563400A0 (en) | Novel receptor | |
| AU1604701A (en) | Mammalian genes; related reagents and methods |